Skip to main content
Clinical Trials/NL-OMON51243
NL-OMON51243
Not yet recruiting
Phase 4

The efficacy of intermittent versus daily oral iron supplementation in anaemic pregnant women. - FER-IDIP trial (FER Intermittent vs Daily In Pregnancy)

Martini Ziekenhuis0 sites58 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Anaemia
Sponsor
Martini Ziekenhuis
Enrollment
58
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Pregnant women of 18 years and older
  • \- Iron deficiency anaemia (defined as: Anaemia (haemoglobin lower than cut\-off
  • value) AND mean corpuscular volume (MCV) 70\-85 fl OR ferritin \<30ug/L) OR mean
  • corpuscular volume (MCV) \< 70fl / hemoglobinopathy is ruled out.
  • \- Adequate mental health
  • \- Good command of the Dutch language
  • \- No participation in other research with medication
  • \- Informed consent

Exclusion Criteria

  • \- Start of iron supplementation at pregnancy duration \> 37 weeks (because of
  • the limited time to achieve an increase in haemoglobin).
  • \- History of bariatric surgery, inflammatory bowel disease, coeliac disease or
  • Helicobacter pylori infection (because of malabsorption of iron).
  • \- Patients who received blood transfusion or parental iron supplementation
  • during the 3 months prior to screening (because of the effect on the
  • haemoglobin level).
  • \- Patients with significant bleeding, blood donation or surgery during
  • pregnancy (because of the effect on the haemoglobin level).
  • \- Allergy for iron.

Outcomes

Primary Outcomes

Not specified

Similar Trials